Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.210
-0.010 (-0.82%)
At close: Sep 26, 2025, 4:00 PM EDT
1.220
+0.010 (0.83%)
After-hours: Sep 26, 2025, 7:57 PM EDT
PACB Employees
Pacific Biosciences of California had 575 employees as of December 31, 2024. The number of employees decreased by 221 or -27.76% compared to the previous year.
Employees
575
Change (1Y)
-221
Growth (1Y)
-27.76%
Revenue / Employee
$271,496
Profits / Employee
-$915,407
Market Cap
363.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PACB News
- 5 days ago - PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes - GlobeNewsWire
- 17 days ago - Pacific Biosciences Of California, Inc. (PACB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 24 days ago - PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow - GlobeNewsWire
- 7 weeks ago - Pacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - PacBio to Present at Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models - GlobeNewsWire
- 2 months ago - Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing - PRNewsWire
- 2 months ago - PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications - GlobeNewsWire